Page last updated: 2024-10-30

lorglumide and Disease Models, Animal

lorglumide has been researched along with Disease Models, Animal in 4 studies

lorglumide: RN given refers to (+-)-isomer
lorglumide : A racemate comprising equal amounts of (R)- and (S)-lorglumide.
N(2)-(3,4-dichlorobenzoyl)-N,N-dipentyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-(3,4-dichlorobenzoyl)glutamic acid with the amino group of dipentylamine.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"In order to elucidate the involvement of cholecystokinin (CCK) in the regulation of anxiety, the author examined the effects of the selective non-peptide CCKB receptor antagonist LY288513 on freezing behavior induced by conditioned fear stress, an animal model of anxiety."7.70[Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety]. ( Izumi, T, 1998)
"In order to elucidate the involvement of cholecystokinin (CCK) in the regulation of anxiety, the author examined the effects of the selective non-peptide CCKB receptor antagonist LY288513 on freezing behavior induced by conditioned fear stress, an animal model of anxiety."3.70[Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety]. ( Izumi, T, 1998)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, CL1
Hung, CR1
Chang, FY1
Pau, KY1
Wang, PS1
Netto, CF1
Guimarães, FS1
Latorre, M1
Bartolomé-Nebreda, JM1
García-López, MT1
González-Muñiz, R1
Herranz, R1
Del Río, J1
Cenarruzabeitia, E1
Izumi, T1

Other Studies

4 other studies available for lorglumide and Disease Models, Animal

ArticleYear
Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by estradiol in ovariectomized rats.
    Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:10

    Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Disease Models, Animal; Estradiol; Female;

2002
Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:1

    Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Cell Count; Disea

2004
Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis.
    Pharmacology, 2004, Volume: 72, Issue:2

    Topics: Acute Disease; alpha-Amylases; Animals; Binding, Competitive; Cerebral Cortex; Cholecystokinin; Deva

2004
[Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1998, Volume: 73, Issue:5

    Topics: Animals; Anxiety; Biogenic Monoamines; Brain; Cholecystokinin; Disease Models, Animal; Hormone Antag

1998